Structure-based discovery of the novel antiviral properties of naproxen against the nucleoprotein of influenza A virus.
about
The Influenza Virus Polymerase Complex: An Update on Its Structure, Functions, and Significance for Antiviral Drug DesignNew small-molecule drug design strategies for fighting resistant influenza ACompounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part II: Future compounds against influenza virusAirborne transmission of highly pathogenic H7N1 influenza virus in ferretsDesigning and screening of universal drug from neem (Azadirachta indica) and standard drug chemicals against influenza virus nucleoproteinChemical Genomics Identifies the PERK-Mediated Unfolded Protein Stress Response as a Cellular Target for Influenza Virus InhibitionProgress of small molecular inhibitors in the development of anti-influenza virus agents.Investigational hemagglutinin-targeted influenza virus inhibitors.CNOT4-Mediated Ubiquitination of Influenza A Virus Nucleoprotein Promotes Viral RNA Replication.Emerging antiviral resistant strains of influenza A and the potential therapeutic targets within the viral ribonucleoprotein (vRNP) complex.Intracellular expression of camelid single-domain antibodies specific for influenza virus nucleoprotein uncovers distinct features of its nuclear localization.Structure-based design of novel naproxen derivatives targeting monomeric nucleoprotein of Influenza A virus.Identification of small molecule inhibitors for influenza a virus using in silico and in vitro approaches.Repurposing FDA-approved drugs for anti-aging therapies.Influenza virus nucleoprotein: structure, RNA binding, oligomerization and antiviral drug target.Antiviral strategies against influenza virus: towards new therapeutic approaches.Learning from structure-based drug design and new antivirals targeting the ribonucleoprotein complex for the treatment of influenza.Using mutagenesis to explore conserved residues in the RNA-binding groove of influenza A virus nucleoprotein for antiviral drug development.Combinations of 1,8-cineol and oseltamivir for the treatment of influenza virus A (H3N2) infection in mice.Influenza A Virus Nucleoprotein: A Highly Conserved Multi-Functional Viral Protein as a Hot Antiviral Drug Target.Type II transmembrane serine proteases as potential target for anti-influenza drug discovery.Identification and synthesis of quinolizidines with anti-influenza a virus activity.Antiviral Protein of Momordica charantia L. Inhibits Different Subtypes of Influenza A.Identification of a novel compound targeting the nuclear export of influenza A virus nucleoprotein.The role of adjuvant immunomodulatory agents for treatment of severe influenza.Re-understanding anti-influenza strategy: attach equal importance to antiviral and anti-inflammatory therapies
P2860
Q28071809-AFDB6706-A053-4B3E-8575-6F9F3DE5FAF8Q28080554-79EBBCFF-1ADF-493C-90E9-57335799C155Q28084005-2C19CC97-B0A8-4C3D-B834-4D99B45725BFQ28387714-069D2D89-2A54-475F-870E-53F64FCE9040Q28817173-A331752E-3E55-4D53-A2B9-CCA48E1E79EBQ28833828-26E2C083-DD56-4A14-A41E-D0BAA74E950BQ30234943-5F027701-F26F-4225-BF24-4B21C33CDA47Q30240175-48E46658-E5E6-4706-9CBC-79309DF859ABQ33721343-A0307F13-9E83-4A3E-9C58-178394D7955EQ34269400-230433E2-7CC6-4DAA-A5F1-3E544F7B372EQ35076701-97287301-1468-498D-879E-504500D1B478Q35993057-F3678DC0-07AD-477F-B939-017B03D1DDB8Q36300881-A3BDD688-2534-425D-B949-C01ADD68D2A0Q37341939-7CD783EE-4992-49BA-94A8-AB764300A997Q38165194-1D95040D-4201-489B-A6CC-7556A8DD2B70Q38202012-1B63A31D-FB29-4718-AB51-8590CF6AE625Q38384758-856B72DB-4E54-4755-B1BE-334A08C5C199Q38641540-A12A276E-3B1A-4735-810D-D134DD70AE2FQ39102455-3CA29A68-4F72-4558-9766-DFCC4F6ED07EQ39152320-15737620-EBC5-46AD-9D3D-6282BDEAAD9AQ40058871-6115AD48-F209-4C3E-B837-9EECDD549DFBQ42198553-B41DD5F6-EED6-4B6A-8165-23041C4AB07FQ42277440-D45EC791-6171-4792-806D-0DA694ECFAE6Q45323947-889101B6-03EE-4A00-B15C-A88CDCB7F13EQ47554935-6ED84EDD-4A2F-494D-B56A-B38DF5E880FDQ57930420-76DA67A3-A194-4508-A1EC-D271086C0E45
P2860
Structure-based discovery of the novel antiviral properties of naproxen against the nucleoprotein of influenza A virus.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Structure-based discovery of t ...... eoprotein of influenza A virus
@nl
Structure-based discovery of t ...... oprotein of influenza A virus.
@ast
Structure-based discovery of t ...... oprotein of influenza A virus.
@en
type
label
Structure-based discovery of t ...... eoprotein of influenza A virus
@nl
Structure-based discovery of t ...... oprotein of influenza A virus.
@ast
Structure-based discovery of t ...... oprotein of influenza A virus.
@en
prefLabel
Structure-based discovery of t ...... eoprotein of influenza A virus
@nl
Structure-based discovery of t ...... oprotein of influenza A virus.
@ast
Structure-based discovery of t ...... oprotein of influenza A virus.
@en
P2093
P2860
P3181
P356
P1476
Structure-based discovery of t ...... oprotein of influenza A virus.
@en
P2093
Anny Slama-Schwok
Bernard Delmas
Bogdan Tarus
Carmelo Di Primo
Edwige Bouguyon
Nathalie Lejal
Nicolas Bertho
Rob W H Ruigrok
Sylvie Chenavas
P2860
P304
P3181
P356
10.1128/AAC.02335-12
P407
P577
2013-03-04T00:00:00Z